Cargando…
How to Interpret an Investigator’s Brochure for Meaningful Risk Assessment: Results of an AGAH Discussion Forum
PURPOSE: A discussion forum was hosted by the Association for Applied Human Pharmacology (AGAH e.V.) to critically debate how to interpret and optimise the Investigator’s Brochure (IB) for meaningful risk assessment of early clinical trials. MATERIALS AND METHODS: Four topics were specifically discu...
Autores principales: | Rengelshausen, Jens, Breithaupt-Groegler, Kerstin, Donath, Frank, Erb-Zohar, Katharina, Hardman, Tim, Mikus, Gerd, Plassmann, Stephanie, Wensing, Georg, Sourgens, Hildegard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857342/ https://www.ncbi.nlm.nih.gov/pubmed/33537954 http://dx.doi.org/10.1007/s43441-021-00257-0 |
Ejemplares similares
-
Use of integrated clinical trial protocols – A survey in early medicines development
por: Erb-Zohar, Katharina, et al.
Publicado: (2018) -
Who is a ‘healthy subject’?—consensus results on pivotal eligibility criteria for clinical trials
por: Breithaupt-Groegler, Kerstin, et al.
Publicado: (2017) -
Unintended drug exposure during pregnancy in clinical trials – a survey in early drug development
por: Erb-Zohar, Katharina, et al.
Publicado: (2021) -
The New First-in-Human EMA Guideline: Disruptive or Constructive? Outcomes From the First EUFEMED Discussion Forum
por: Breithaupt-Grögler, Kerstin, et al.
Publicado: (2019) -
Discussion and closing of the Forum
por: CERN. Geneva
Publicado: (2012)